Fortrea Holdings Inc., a global contract research organization spun off from Labcorp in mid-2023, leverages broad clinical expertise and a flexible service model across approximately 100 countries. While operating cash flow remains positive, the company has reported significant net losses driven by restructuring costs and legacy operational challenges, alongside a substantial debt burden. Its exit from the Enabling Services segment marks a strategic focus on core clinical services but underscores transitional pressures. Customer concentration and regulatory complexities persist as notable risks in the near to medium term.